Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-1426

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience ; volume:6 ; number:1 ; day:29 ; month:5 ; year:2018 ; pages:1-6 ; date:12.2018
Journal for ImmunoTherapy of Cancer ; 6, Heft 1 (29.5.2018), 1-6, 12.2018

Creator: Salhab, Mohammed

Contributor: Migdady, Yazan
Donahue, Melanie
Xiong, Yiqin
Dresser, Karen
Walsh, William
Chen, Benjamin J.
Liebmann, James
SpringerLink (Online service)

DOI: 10.1186/s40425-018-0359-1

URN: urn:nbn:de:101:1-2018082022092298158265

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Salhab, Mohammed
Migdady, Yazan
Donahue, Melanie
Xiong, Yiqin
Dresser, Karen
Walsh, William
Chen, Benjamin J.
Liebmann, James
SpringerLink (Online service)

Other Objects (12)

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC)

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-L1 Expression als Prognosemarker beim Endometriumkarzinom

Factors correlating the expression of PD-L1

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC)

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-L1 Expression als Prognosemarker beim Endometriumkarzinom

Factors correlating the expression of PD-L1

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC)

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-L1 Expression als Prognosemarker beim Endometriumkarzinom

Factors correlating the expression of PD-L1

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC)

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-L1 Expression als Prognosemarker beim Endometriumkarzinom

Factors correlating the expression of PD-L1

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC)

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-L1 Expression als Prognosemarker beim Endometriumkarzinom

Factors correlating the expression of PD-L1

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC)

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-L1 Expression als Prognosemarker beim Endometriumkarzinom

Factors correlating the expression of PD-L1

Related objects

Reset password